Timo Minssen

Researcher
More filtering options
  1. 2020
  2. Preparing for antimicrobial resistance in the wake of the COVID-19 pandemic: The vision and “social science” mission of the INAMRSS network

    Timo Minssen, Kevin Outterson, Susan Rogers Van Katwyk, Pedro Henrique D. Batista, Clare Chandler, Francesco Ciabuschi, Stephan Harbarth, Aaron Kesselheim, Ramanan Laxminarayan, Kathleen Liddell, Michael T. Osterholm, Lance B Price & Steven J. Hoffman, 2020 Dec 11, Harvard Law School's Bill of Health blog.

    Research output: Other contributionWeb publication/Blog post

  3. Social, cultural and economic aspects of antimicrobial resistance

    Timo Minssen, Kevin Outterson, Susan Rogers Van Katwyk, Pedro Henrique D. Batista, Clare Chandler, Francesco Ciabuschi, Stephan Harbarth, Aaron Kesselheim, Ramanan Laxminarayan, Kathleen Liddell, Michael T. Osterholm, Lance Price & Steven J. Hoffman, 2020 Dec 3, In: Bulletin of the World Health Organization. 98, 12, p. 823-824 2 p.

    Research output: Contribution to journalArticle

  4. At the Epicentre of COVID-19 - the Tragic Failure of the Global Supply Chain for Medical Supplies

    Sonu Bhaskar, Jeremy Tan, Marcel Bogers, Timo Minssen, Hishamuddin Badaruddin, Simon Israeli-Korn & Henry Chesbrough, 2020 Nov 24, In: Frontiers in Public Health. 9 p.

    Research output: Contribution to journalArticle

  5. A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways

    Louise C. Druedahl, Anna Birna Almarsdóttir, Sofia Kälvemark Sporrong, Marie Louise De Bruin, Hans Hoogland, Timo Minssen, Marco van de Weert, Aaron S. Kesselheim & Ameet Sarpatwari, 2020 Nov 1, In: Nature Biotechnology. 38, 11, p. 1253-1256 4 p.

    Research output: Contribution to journalArticle

  6. ELSI Implications of Prioritizing Biological Therapies in the Times of COVID-19

    Louise C. Druedahl, Audrey Lebret & Timo Minssen, 2020 Oct 1, In: Journal of Law, Medicine & Ethics. 48, 3, p. 579-582 4 p.

    Research output: Contribution to journalArticle

  7. Knowledge transfer for large scale vaccine manufacturing

    William Nicholson Price II, Arti Rai & Timo Minssen, 2020 Aug 13, In: Science. 369, 6506, p. 912-914 3 p.

    Research output: Contribution to journalArticle

  8. Applying the Proportionality Principle to COVID-19 Antibody Testing

    H D Gunnarsdóttir, M S Sinha, S Gerke & T Minssen, 2020 Aug 1, In: Journal of Law and the Biosciences.

    Research output: Contribution to journalArticle

  9. AIRR Data Under the E.U. Trade Secrets Directive: Aligning Scientific Practices with Commercial Realities

    Jacob S. Sherkow & Timo Minssen, 2020 Jul 9, The harmonization and protection of trade secrets in the EU – An Appraisal of the EU Directive. Schovsbo, J., Riis, T. & Minssen, T. (eds.). United Kingdom: Edward Elgar Publishing, p. 239-268 30 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  10. Book introduction: An Appraisal of the EU Directive on Trade Secrets

    Jens Hemmingsen Schovsbo, Timo Minssen & Thomas Riis, 2020 Jul 9, The harmonization and protection of trade secrets in the EU. Schovsbo, J., Minssen, T. & Riis, T. (eds.). United Kingdom: Edward Elgar Publishing, p. 1-7 7 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  11. The harmonization and protection of trade secrets in the EU: – An Appraisal of the EU Directive

    Jens Hemmingsen Schovsbo, Timo Minssen & Thomas Riis, 2020 Jul 9, United Kingdom: Edward Elgar Publishing.

    Research output: Book/ReportBook

  12. Ethical and Legal Challenges of Artificial Intelligence-Driven Health Care

    Sara Gerke, Timo Minssen & Glenn Cohen, 2020 Jun 23, Artificial Intelligence in Healthcare. Bohr, A. & Memarzadeh, K. (eds.). 1 ed. Netherlands: Elsevier, p. 295-336 42 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  13. The European Artificial Intelligence Strategy: Implications and Challenges for Digital Health

    Glenn Cohen, Theodoros Evgeniou, Sara Gerke & Timo Minssen, 2020 Jun 23, In: The Lancet Digital Health. 2, 7, p. 376-379 4 p.

    Research output: Contribution to journalArticle

  14. Denmark

    Timo Minssen, Tue Goldschmieding & Søren Sandfeld Jakobsen, 2020 May 22, AI, Big Data & Machine Learning. 2 ed. Global Legal Insights (GLI), p. 113-128 16 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  15. Regulatory responses to medical machine learning

    Timo Minssen, Sara Gerke, Mateo Aboy, William Nicholson Price II & Glenn Cohen, 2020 Apr 1, In: Journal of Law and the Biosciences. 7, 1, p. 1-18 18 p.

    Research output: Contribution to journalArticle

  16. Establishing the First International Genetic Discrimination Observatory

    Yann Joly, Gratien Dalpe, Timo Minssen, Katharina Ó Cathaoir, Aisling De Paor, Palmira Granados Moreno, Edward Dove, Ine van Hoyweghen, Chih-hsing Ho, Calvin WL Ho, Hannah Kim, Lingqiao Song, Margaret Otlowski, Anya Prince, TH Voigt, A Thiraps, Maria Pilar, Bénédicte BEVIERE BOYER, Chisato Yamasaki, Yvonne Bombard & 1 others, Charles Dupras, 2020 Mar 23, In: Nature Genetics. 52, p. 466-468 3 p.

    Research output: Contribution to journalArticle

  17. Clinical trial data transparency and GDPR compliance: Implications for data sharing and open innovation

    Timo Minssen, Neethu Rajam & Marcel Bogers, 2020 Mar 1, In: Science and Public Policy.

    Research output: Contribution to journalArticle

  18. One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?

    Mateo Aboy, Cristina Crespo, Kathleen Liddell, Neil Davey, Johnathon Liddicoat & Timo Minssen, 2020 Mar 1, In: Nature Biotechnology. 38, 3, p. 279-283 5 p.

    Research output: Contribution to journalArticle

  19. An EU Comparative Analysis of the Regulation of Clinical Trials Supervisory Bodies in the Aftermath of Regulation 536/2014

    Iñigo de Miguel Beriain, Theodora Chortara, Aliuska Duardo-Sánchez, Oliver Feeney, Heike Felzmann, Emma Fernández de Uzquiano, Elisa Lievevrouw, Luca Marelli, Titti Mattsson, Janne Rothmar Herrmann, Timo Minssen, Elisabetta Pulice, Vera Lúcia Raposo, Jürgen Robienski, Simone Penasa & Ine Van Hoyweghen, 2020, In: European Public Law. 26, 2, p. 307-330 24 p.

    Research output: Contribution to journalArticle

  20. Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries

    Sara Gerke, Ariel D. Stern & Timo Minssen, 2020, In: npj Digital Medicine. 3, 94.

    Research output: Contribution to journalArticle

  21. 2019
  22. Homomorphic Encryption: The ‘Holy Grail’ for Big Data Analytics & Legal Compliance in the Pharmaceutical and Healthcare Sector?

    Marcelo Corrales Compagnucci, Janos Meszaros, Timo Minssen, Arasaratnam Arasilango, Talal Ous & Muttukrshnan Rajarajan, 2019 Dec 23, In: European Pharmaceutical Law Review. 3, 4, p. 144-155 12 p.

    Research output: Contribution to journalArticle

  23. AIPPI Report for Denmark on Plausibility in Patent Law: AIPPI 2019 - 2019 Study Questions - Plausibility

    Ulla Callesen Klinge, Anders Valentin, Jeppe Brinck-Jensen, Nikolai Dokkedahl, Thomas Bækmark, Lise Tølbøll, Sture Rygaard, Casper Struve, Klaus Ewald Madsen, Lars Pallisgaard, Torben Ravn, Mikkel Vittrup, Timo Minssen, Nicolai Lindgreen & Tobias Triton Frost, 2019 Nov 1

    Research output: Book/ReportBook

  24. How does emerging patent case law in the US and Europe affect precision medicine?

    Mateo Aboy, Kathleen Liddell, Cristina Crespo, I. Glenn Cohen, Johnathon Liddicoat, Sara Gerke & Timo Minssen, 2019 Oct 1, In: Nature Biotechnology. 37, 10, p. 1118-1125 8 p.

    Research output: Contribution to journalArticle

  25. Nudges or Shoves in the Secondary Use of Health Data: What is the More Desirable Approach? (Part 2)

    Marcelo Corrales Compagnucci, Janos Meszaros & Timo Minssen, 2019 Sep 25, Harvard Law School's Bill of Health blog.

    Research output: Other contributionMiscellaneous

  26. Nudges or Shoves in the Secondary Use of Health Data: What is the More Desirable Approach? (Part I)

    Marcelo Corrales Compagnucci, Janos Meszaros & Timo Minssen, 2019 Sep 24, Harvard Law School's Bill of Health blog.

    Research output: Other contributionMiscellaneous

  27. Is Data Sharing Caring Enough About Patient Privacy?: Part I: The Background

    Timo Minssen, Sara Gerke & Carmel Shachar, 2019 Jul 26, Harvard Law School's Bill of Health blog.

    Research output: Other contributionMiscellaneous

  28. Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine

    Mateo Aboy, Cristina Crespo, Kathleen Liddell, Timo Minssen & Johnathan Liddicoat, 2019 May 1, In: Nature Biotechnology. 37, p. 513-518 6 p.

    Research output: Contribution to journalArticle

  29. The problem with antibiotics

    Jonathan Darrow & Timo Minssen, 2019 May 1, In: The Economist. 431, 9144, p. 20 1 p.

    Research output: Contribution to journalArticle

  30. Much ado about something. Legal, ethical, and scientific challenges in international biobanking and translational exploitation

    Timo Minssen, Janne Rothmar Herrmann & Jens Hemmingsen Schovsbo, 2019 Apr 9, Global Genes, Local Concerns: Legal, Ethical, and Scientific Challenges in International Biobanking. Minssen, T., Rothmar Herrmann, J. & Schovsbo, J. (eds.). United Kingdom: Edward Elgar Publishing, Vol. 1. p. IX - XV

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  31. Global Genes, Local Concerns: Legal, Ethical and Scientific Challenges in International Biobanking

    Timo Minssen, Janne Rothmar Herrmann & Jens Hemmingsen Schovsbo, 2019 Apr 1, United Kingdom: Edward Elgar Publishing.

    Research output: Book/ReportBook

  32. What lurks in the shadows of the openness hyperbole for biopharmaceuticals?

    R. Neethu & Timo Minssen, 2019 Mar 1, In: Drug Development Research.

    Research output: Contribution to journalDebate/Note/Editorial

  33. Shadow health records meet new data privacy laws

    William Nicholson Price II, Kayte Spector-Bagdady, Timo Minssen & Margot Kaminski, 2019 Feb 1, In: Science. 363, 6426, p. 448-450 3 p.

    Research output: Contribution to journalArticle

  34. An "export-only" exception to pharmaceutical patents in Europe: Should the U.S. follow suit?

    Timo Minssen, Aaron Kesselheim & Jonathan Darrow, 2019 Jan 3, In: Nature Biotechnology. 37, 1, p. 21-22 2 p.

    Research output: Contribution to journalArticle

  35. 2018
  36. Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?

    Jakob Wested, Timo Minssen & Esther Van Zimmeren, 2018 Jul 13, In: Life Sciences Intellectual Property Review (LSIPR). 13/7 2018

    Research output: Contribution to journalArticle

  37. Big Data in the Health and Life Sciences: What Are the Challenges for European Competition Law and Where Can They Be Found?

    Timo Minssen & Jens Hemmingsen Schovsbo, 2018 Jun 1, Intellectual Property and Digital Trade in the Age of Artificial Intelligence and Big Data. Seuba, X., Geiger, C. & Pénin, J. (eds.). Centre d'études internationales de la propriété intellectuelles (CEIPI), p. 121-130 10 p. (CEIPI / ICTSD Publication Series on Global Perspectives and Challenges for the Intellectual Property System).

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  38. Patentability Standards for Follow-on Pharmaceutical Innovation

    Christopher M. Holman, Timo Minssen & Eric M. Solovy, 2018 Jun 1, In: Biotechnology Law Report. 37, 3, p. 131-161 31 p.

    Research output: Contribution to journalArticle

  39. Big Data and intellectual property rights in the health and life sciences

    Timo Minssen & Justin Pierce, 2018 Mar 8, Big Data, Health Law, and Bioethics. Cambridge University Press, p. 311-323 13 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  40. A Ray of Light in Muddy Waters? -The CJEU rules on combination SPCs in C-121/17 Teva v Gilead

    Timo Minssen & Sven Bostyn, 2018, In: European Pharmaceutical Law Review. 2, 3, p. 169-173 5 p.

    Research output: Contribution to journalArticle

  41. Challenges for the sustainability of university-run biobanks

    Nana Cecilie Halmsted Kongsholm, Søren Tvorup Christensen, Janne Rothmar Herrmann, Lars Allan Larsen, Timo Minssen, Lotte Bang Pedersen, Neethu Rajam, Niels Tommerup, Aaro Mikael Tupasela & Jens Hemmingsen Schovsbo, 2018, In: Biopreservation and Biobanking. 16, 4, p. 312-321 10 p.

    Research output: Contribution to journalArticle

  42. Clearing a way through the CRISPR patent jungle

    Timo Minssen, Esther Van Zimmeren & Jakob Wested, 2018, In: Life Sciences Intellectual Property Review (LSIPR). 8/5 2018

    Research output: Contribution to journalArticle

  43. How much is too much?- Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector

    Behrang Kianzad & Timo Minssen, 2018, In: European Pharmaceutical Law Review. 2, 3, p. 133-148 16 p.

    Research output: Contribution to journalArticle

  44. Reap what you sow! - But what about SPC squatting?

    Jens Hemmingsen Schovsbo, Ulla Callesen Klinge & Timo Minssen, 2018, In: Journal of Intellectual Property Law & Practice. 13, 7, p. 569-580 12 p.

    Research output: Contribution to journalArticle

  45. 2017
  46. Patenting Human Genes in Europe: and how it compares to the US and Australia

    Timo Minssen, 2017 Jul 1, Research Handbook on Intellectual Property and the Life Sciences. Matthews, D. & Zech, H. (eds.). United Kingdom: Edward Elgar Publishing, p. 26-39 14 p. (Research Handbooks in Intellectual Property series).

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  47. 2016
  48. Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines

    Rasmus Borup, Susanne Kaae, Timo Minssen & Janine Marie Traulsen, 2016 Oct 6, In: Journal of Pharmaceutical Policy and Practice. 30, 9, p. 1-8 8 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 Next